Laboratory Monitoring After Postpartum Hemorrhage
After postpartum hemorrhage, prioritize serial fibrinogen levels as the most critical laboratory test, supplemented by complete blood count (CBC) with platelet count, and consider point-of-care viscoelastic testing (ROTEM/TEG) if available for rapid coagulation assessment.
Essential Laboratory Tests to Obtain
Primary Tests (Obtain Immediately)
Fibrinogen level: This is the single most important coagulation parameter in PPH 1, 2. Fibrinogen correlates best with blood loss severity (r = -0.48) and falls progressively as hemorrhage volume increases 1. The critical threshold is <2.0 g/L, which predicts progression to severe hemorrhage and need for massive transfusion 3.
Complete Blood Count (CBC): Obtain hemoglobin and platelet count. Platelets should not fall below 50 × 10⁹/L in actively bleeding patients 4. However, note that hemoglobin may be falsely reassuring initially due to acute blood loss without equilibration 1.
Viscoelastic Testing (ROTEM/TEG): If available, this provides rapid results (within minutes vs. hours for standard labs) 3, 5, 2. The FIBTEM A5 <12 mm threshold on ROTEM correlates with fibrinogen <2.1 g/L and predicts need for massive transfusion 3.
Secondary Tests
PT/INR and aPTT: These are less sensitive markers in PPH. They often remain within normal range despite significant blood loss and only become abnormal after severe coagulopathy develops 1. PT showed no correlation with blood loss in one large study 1.
Antithrombin activity: Correlates well with estimated blood loss in severe PPH 2.
D-dimer/Fibrinogen degradation products: Useful if disseminated intravascular coagulation (DIC) is suspected 4.
Monitoring Frequency
Repeat coagulation studies frequently during active bleeding 4. The specific interval depends on:
- Ongoing hemorrhage: Every 30-60 minutes during active resuscitation
- After initial control: Every 2-4 hours until stabilized
- Blood loss >2000 mL: Expect significant coagulopathy and monitor more aggressively 2
The turnaround time for standard laboratory tests may necessitate requesting blood components before results are available if bleeding is rapid 4.
Critical Thresholds for Intervention
Based on the evidence, intervene when:
- Fibrinogen <2.0 g/L (or FIBTEM A5 <12 mm): Administer cryoprecipitate or fibrinogen concentrate 3
- Fibrinogen <1.0 g/L: Critical level requiring urgent correction 4
- Platelets <50 × 10⁹/L: Transfuse platelets (target may be higher at 100 × 10⁹/L for severe trauma) 4
- PT/aPTT >1.5 times normal: Indicates increased risk of clinical coagulopathy requiring fresh frozen plasma 4
Important Caveats
Standard coagulation tests have significant limitations in PPH 1, 5:
- Traditional PT/aPTT are insensitive to early coagulopathy in PPH and have long turnaround times
- Current transfusion guidelines based on non-pregnant populations are often not followed in practice—only 3% of women in one study met criteria for FFP, yet 45 received it 1
- Pregnancy creates a hypercoagulable baseline state, so "normal" reference ranges don't apply 5
- Viscoelastic testing cannot detect von Willebrand disease, platelet dysfunction from antiplatelet agents, or endothelial disorders 3
The evidence strongly supports that fibrinogen is the first coagulation factor to reach critical levels (after ~150% blood loss), followed by other labile factors (after ~200% blood loss) 4. This makes fibrinogen monitoring paramount.
Practical Algorithm
- At PPH diagnosis (>1000 mL ongoing bleeding): Obtain baseline CBC, fibrinogen, PT/aPTT, and ROTEM/TEG if available 6
- During active resuscitation: Repeat fibrinogen and CBC every 30-60 minutes
- If fibrinogen <2.0 g/L or FIBTEM A5 <12 mm: Administer targeted therapy immediately
- Monitor for DIC: If prolonged hypoxia, hypovolemia, or hypothermia present, add D-dimer and watch for platelet drop with fibrinogen <1.0 g/L 4
- After stabilization: Continue monitoring every 2-4 hours until values normalize